🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05985447
Recruiting Observational

Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity

NCT05985447 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2022-03-07
Last updated
2023-08-14

Condition(s) studied

ArteriosclerosisAcute Myocardial InfarctionCardiovascular EventsMenopause

Study summary

Women and men show marked differences in cardiovascular risk profile and outcome. Women experience fewer cardiovascular events than men before menopause, but this relationship seems to reverse at menopause. These disparities are probably due to hormonal factors, especially the female sex hormone estrogen seems to have a protective influence on the development of atherosclerotic plaques premenopausal.

The underlying mechanisms of the effect of estrogens on the vessel wall are still insufficiently investigated. In this study, menopause related effects on leukocyte distribution and function as well on platelets and their aggregational response will be evaluated.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age \> 18 years * Male, female, diverse patients with current treatment in the Department of Cardiology, Pneumology and Angiology. * Persons who are able to understand and follow the instructions of the study staff * Written informed consent Exclusion Criteria: * Age \< 18 years * Lack of written consent to participate in the study * coagulation disorders

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular Medicine Düsseldorf Germany Recruiting

More Heinrich-Heine University, Duesseldorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05985447 on ClinicalTrials.gov ↗ ← All trials in Germany